2023

1. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

   European Journal of Cancer, Vol. 185, pp. 105-118

2. Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study

   Cancers, Vol. 15, Núm. 21